Long Beach-based Agilon Health Inc. raised approximately $1.07 billion through its initial public offering.
Culver City-based NantHealth Inc. announced a $137 million financing package that will be provided by two of its existing investors.
Long Beach-based Agilon Health Inc., which helps primary care physician groups to cap costs for their Medicare Advantage patients, is seeking to raise up to $1.7 billion from its IPO.
City of Hope Researcher Arthur Riggs Helped Create Artificial Insulin, Now Emerges as Its Largest Donor
Arthur Riggs, a pioneer of the modern biotech industry and developer of artificial insulin has donated over $300 million to City of Hope.
Long Beach-based Agilon Health Inc., which helps primary care physician groups cap costs for their Medicare Advantage patients, filed paperwork on March 18 with the Securities and Exchange Commission to become a publicly traded company.
USC has selected University of Pittsburgh Medical Center executive Steven Shapiro to fill a newly created role to guide the school’s health sciences programs starting May 15.
Santa Monica-based Kite Pharma announced March 5 that the Food and Drug Administration has granted accelerated approval for the company’s principal drug, Yescarta, for the treatment of adult patients with relapsed follicular lymphoma after two or more other therapies had already been applied.
The LABJ Interview
CEO John Agwunobi sat down with the Business Journal to discuss the pandemic’s impact on Herbalife, his unique perspective on pandemic preparedness and more.
The XPrize Foundation awarded a total of $6 million to five groups for developing affordable Covid-19 rapid tests.
Ontrak Inc., which recently announced that it would be losing its largest customer, has named CVS Health executive Jonathan Mayhew as its new CEO.
The biggest change in years for billionaire Patrick Soon-Shiong’s family of biotech businesses was completed last week.
Santa Monica-based GoodRx Holdings Inc. reported a 42% jump in revenue for 2020 in the company’s second quarterly earnings report since going public.
Custom Content: Developing The Right Program For Your Organization
Developing The Right Program For Your Organization. With infertility affecting 1 in 8 individuals in the U.S., many Americans wish to remove the stigmas and barriers that stand in the way of building families.
BreathDirect, a startup Long Beach medical device company, has received emergency use authorization from the Food and Drug Administration to market its low-cost medical ventilator.
Westwood-based ChromaDex Corp. has reached an agreement to place its TruNiagen nutrition supplement in 3,000 Walmart stores.